Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Saline Solution × Gynecologic × Clear all

Phase

Status

Completed 6 Active not recruiting 3 Unknown 2 Terminated 2 Not yet recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Gastrointestinal 4 Breast 4 Lymphoid 3 Other solid neoplasm 2 Plasma cell 1 Other hematologic neoplasm 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 69 pembrolizumab 58 Carboplatin 58 Bevacizumab 49 Cisplatin 39 Specimen Handling 30 Drug Therapy 22 olaparib 21 Blood Specimen Collection 21 Biopsy 19 Magnetic Resonance Spectroscopy 18 Cyclophosphamide 15 Taxes 14 Letrozole 14 niraparib 13 fludarabine 12 Gemcitabine 12 liposomal doxorubicin 10 abemaciclib 10 Radiotherapy 10 Fulvestrant 10 dostarlimab 9 Nivolumab 9 Doxorubicin 9 Docetaxel 9 Brachytherapy 9 mirvetuximab soravtansine 8 lenvatinib 8 camrelizumab 8 Topotecan 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06888921 2026-02-27

MAIA-ovarian

Compugen Ltd

Phase 1/2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡